Children's Hospital is part of the UPMC family.
This multicenter trial by the Children’s Oncology Group trial studies different chemotherapy and radiation therapy regimens to compare how well they work in treating young patients with newly diagnosed, previously untreated, high-risk medulloblastoma. In particular, investigators will be examining whether carboplatin in combination with radiation is more effective on tumor cells than radiation alone.
Subject to certain exclusion criteria, this study is open to patients of both genders ages 3 to 21, who have been diagnosed as having M0 medulloblastoma, M+ medulloblastoma or diffusely anaplastic medulloblastoma.
Males and Females: Ages 3 to 21
There are two arms to the study. Arm A is standard chemoradiotherapy and maintenance therapy; Arm B adds carboplatin to the chemoradiotherapy. The chemoradiotherapy portion of each arm is 6 weeks followed by a 6-week rest period. The maintenance and continuation stages comprise 6, 28-day cycles.
Visits: Same number as required with standard therapy
Duration: Approximately 9 to15 months depending on study arm
Children’s Oncology Group (ACNS0322)
National Cancer Institute
Study Description at National Institutes of Health
Jean Tersak, MD
For more information about the study or enrollment, please contact:
Research Coordinator Angela Connelly, RN, BSN
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
Children’s Hospital of Pittsburgh of UPMC
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to: